Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipid A (Lipid A)

Target
Lipid A
Molecular classification
Glycolipid, Bacterial cell wall component, Endotoxin
01

Overview

Lipid A is a highly conserved phosphoglycolipid that serves as the hydrophobic anchor for lipopolysaccharide (LPS) in the outer leaflet of the Gram-negative bacterial outer membrane (Source: NIH). It is vital for maintaining the structural integrity of the bacterial cell envelope and functions as a potent permeability barrier against detergents and antibiotics (Source: PubMed). Clinically, Lipid A is the primary endotoxin responsible for the pathophysiology of Gram-negative sepsis and septic shock (Source: StatPearls). It acts as a pathogen-associated molecular pattern (PAMP) that is recognized by the host's Toll-like receptor 4 (TLR4)/MD-2 complex, initiating a massive pro-inflammatory cytokine cascade (Source: UniProt). Drugs such as polymyxins target Lipid A by binding to its negatively charged phosphate groups, which displaces stabilizing divalent cations and leads to membrane disruption (Source: PubMed). Additionally, novel therapeutic approaches focus on inhibiting Lipid A biosynthesis enzymes, such as LpxC, or neutralizing its activity to prevent overwhelming immune activation (Source: NIH).

Other names
EndotoxinLipopolysaccharide lipid ALPS lipid ALipid A component of the outer membrane
02

Mechanism of action

Displacement of divalent cations from phosphate groups leading to membrane disruption; inhibition of lipid A biosynthesis; and competitive antagonism of the TLR4/MD-2 receptor complex.

03

Biological functions

Structural integrity of the outer membranePermeability barrierImmune response activationEndotoxic activity
04

Disease associations

Gram-negative bacterial infectionSepsisSeptic shockInflammation
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionSystemic inflammatory response
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin levels (LAL assay)ProcalcitoninC-reactive proteinInterleukin-6

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipid A (Lipid A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipid A (Lipid A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call